Efficacy and Safety of SGLT2 Inhibitors and GLP ‐1 Receptor Agonists on Ventricular Arrhythmias and Cardiovascular Events: A Disease‐Stratified Network Meta‐Analysis
Year: 2026
Type: review
Study designs: Systematic Review, Meta-Analysis
Source: Diabetes Obesity and Metabolism
DOI: 10.1111/dom.71094
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: SGLT2 inhibitors, GLP-1 receptor agonists, ventricular arrhythmias, type 2 diabetes, heart failure, cardiovascular mortality, all-cause mortality, heart failure hospitalization, empagliflozin, dapagliflozin, liraglutide, albiglutide, semaglutide, acute kidney injury, hypoglycemia, diabetic ketoacidosis
Open Access status: closed
Award: G8610550454
OpenAlex ID: W7167828459
